全文获取类型
收费全文 | 103746篇 |
免费 | 5740篇 |
国内免费 | 280篇 |
专业分类
耳鼻咽喉 | 1310篇 |
儿科学 | 2386篇 |
妇产科学 | 2132篇 |
基础医学 | 13911篇 |
口腔科学 | 4915篇 |
临床医学 | 8087篇 |
内科学 | 24563篇 |
皮肤病学 | 2367篇 |
神经病学 | 8848篇 |
特种医学 | 2434篇 |
外国民族医学 | 2篇 |
外科学 | 13253篇 |
综合类 | 541篇 |
一般理论 | 35篇 |
预防医学 | 10133篇 |
眼科学 | 1877篇 |
药学 | 7137篇 |
中国医学 | 502篇 |
肿瘤学 | 5333篇 |
出版年
2023年 | 672篇 |
2022年 | 699篇 |
2021年 | 2134篇 |
2020年 | 1341篇 |
2019年 | 2072篇 |
2018年 | 3276篇 |
2017年 | 2149篇 |
2016年 | 2236篇 |
2015年 | 2902篇 |
2014年 | 3258篇 |
2013年 | 4410篇 |
2012年 | 8726篇 |
2011年 | 9076篇 |
2010年 | 4202篇 |
2009年 | 3076篇 |
2008年 | 7328篇 |
2007年 | 7593篇 |
2006年 | 7253篇 |
2005年 | 7015篇 |
2004年 | 6345篇 |
2003年 | 5788篇 |
2002年 | 5412篇 |
2001年 | 2177篇 |
2000年 | 2686篇 |
1999年 | 1502篇 |
1998年 | 421篇 |
1997年 | 304篇 |
1996年 | 268篇 |
1995年 | 261篇 |
1994年 | 242篇 |
1993年 | 215篇 |
1992年 | 418篇 |
1991年 | 353篇 |
1990年 | 311篇 |
1989年 | 288篇 |
1988年 | 244篇 |
1987年 | 179篇 |
1986年 | 224篇 |
1985年 | 221篇 |
1984年 | 201篇 |
1983年 | 159篇 |
1982年 | 153篇 |
1981年 | 122篇 |
1980年 | 127篇 |
1979年 | 144篇 |
1978年 | 115篇 |
1974年 | 106篇 |
1973年 | 93篇 |
1969年 | 101篇 |
1967年 | 97篇 |
排序方式: 共有10000条查询结果,搜索用时 437 毫秒
991.
Berti M Albertin A Casati A Palmisano S Municino G da Gama Malcher M De Ponti A 《Minerva anestesiologica》2000,66(7-8):549-554
BACKGROUND: This prospective, randomized study was conducted to evaluate the quality of postoperative pain relief when using dexketoprofen, ketoprofen, or paracetamol after outpatient knee arthroscopy. METHODS: Without premedication, 45 ASA physical status I-II patients undergoing elective outpatient knee arthroscopy with combined sciatic-femoral nerve block, were randomly allocated to receive either 25 mg oral dexketoprofen (n = 15), 50 mg oral ketoprofen (n = 15), or 500 mg oral paracetamol (n = 15) before block placement. After completion of surgery the same pain medication was given according to standard protocols, while 50 mg oral tramadol were allowed as rescue analgesic if required by the patient. After standard discharge criteria had been fulfilled, patients were discharged from the day-surgery unit, while a telephone follow-up was performed the day after surgery using standard questionnaires evaluating the quality of pain relief during the first 24 hours after surgery. Total consumption of rescue tramadol, maximum pain complained of after hospital discharge, as well as the visual analogue scale of pain measured at hospital discharge were assessed by an independent trained observer. RESULTS: No differences in anthropometric variables, duration of surgical procedure, and fulfillment of discharge criteria were observed between the three groups. The degree of pain measured at rest at hospital discharge was similar in the three groups, while the VAS measured during motion was higher in patients receiving paracetamol (24 +/- 2.5 mm) than in those patients treated with dexketoprofen (13 +/- 6 mm) or ketoprofen (17 +/- 5 mm) (p = 0.016). Two patients (one in ketoprofen group and one in paracetamol group) required rescue tramadol after hospital discharge; however, no differences in maximum pain complained of after surgery or patient acceptance were observed between groups. CONCLUSIONS: This prospective, randomized study demonstrated that in outpatients receiving arthroscopic knee surgery, the use of 75 mg/day dexketoprofen was as effective and safe as 150 mg/day racemate ketoprofen, with a better pain relief during motion compared to 2 g/day paracetamol when patients were discharged from the day-surgery unit. 相似文献
992.
Bitar R Flores O Reverte M López-Novoa JM Macías JF 《International urology and nephrology》2000,32(2):165-169
This study analysed the effect of low doses ofverapamil added to chronic treatment withangiotensin-converting enzyme (ACE)
inhibitors onblood pressure and serum creatinine levels in eightelderly hypertensive patients who had a steadyincrease of
serum creatinine while on ACE inhibitors.The study was performed in eight elderly hypertensivesubjects, five men and three
women (mean age 70 ±2 years; systolic blood pressure 173 ± 4 mmHg; diastolic blood pressure 99 ± 1 mm Hg) andserum creatinine
of 1.60 ± 0.27 mg/dl beforetreatment. During an average of 25 weeks, ACEinhibitors significantly reduced both systolic anddiastolic
blood pressures, but serum creatinine levelswere increased over basal levels (0,68 ± 0,20 mg/dl, p < 0.05). During an average of 10 weeks,the addition of verapamil did not decrease bloodpressure further, but serum creatinine
levels werereduced to baseline. Our study suggests that theaddition of verapamil to ACE inhibitors can reverseACE-induced
increase in creatinine levels in elderlyhypertensive patients in whom this side effect isobserved.
This revised version was published online in August 2006 with corrections to the Cover Date. 相似文献
993.
M. Cruz J.M. Tusell D. Grillo‐Bosch F. Albericio J. Serratosa F. Rabanal E. Giralt 《Chemical biology & drug design》2004,63(3):324-328
Abstract: Single N‐methyl amino acid‐containing peptides related to the central hydrophobic region β16–20 (Lys‐Leu‐Val‐Phe‐Phe) of the β‐amyloid protein are able to reduce the cytotoxicity of natural β1–42 in PC12 cell cultures. N‐methyl phenylalanine analogs yield statistically significant increments in cell viability (Student's t‐test < 0.01%) and are nontoxic in the same assay. These promising results indicate that these peptide molecules could be a starting point for the development of potential therapeutic compounds for the treatment of Alzheimer's disease. 相似文献
994.
Detry O Honoré P Hans MF Delbouille MH Jacquet N Meurisse M 《Transplantation》2000,70(1):244-8; discussion 251-2
Patients with primary central nervous system (CNS) tumor have been accepted for organ donation because these tumors very rarely spread outside the CNS. However several case reports of CNS tumor transferral with organ transplantation recently challenged this attitude. Some risk factors for extraneural spread of CNS tumors have been determined, but the absence of risk factors does not exclude the possibility of metastases. To our knowledge, 13 cases of CNS tumor transferral with organ transplantation (one heart, three livers, eight kidneys, one kidney/pancreas) have been reported in the literature. Even if no prospective evaluation of the CNS tumor transmission risk with transplantation has been undergone, this risk may be estimated between a little more than 0% and 3% from retrospective series. The authors consider that patients with CNS tumor should be accepted as donors as long as the risk of dying on the waiting lists is significantly higher than the tumor transferral risk. Therefore the authors would have no restriction for transplanting organs from donors with benign or low-grade CNS tumor. For high-grade tumors, the authors would consider these donors as "marginal donors," and balance the risk of tumor transmission with the medical condition of the recipient. 相似文献
995.
Iranzu González Enrique J Andreu Angel Panizo Susana Inogés Ana Fontalba José Luis Fernández-Luna Mirella Gaboli Luis Sierrasesúmaga Salvador Martín-Algarra Javier Pardo Felipe Prósper Enrique de Alava 《Clinical cancer research》2004,10(2):751-761
PURPOSE AND EXPERIMENTAL DESIGN: The stem cell factor/KIT receptor loop may represent a novel target for molecular-based therapies of Ewing tumor. We analyzed the in vitro impact of KIT blockade by imatinib in Ewing tumor cell lines. RESULTS: KIT expression was detected in 4 of 4 Ewing tumor cell lines and in 49 of 110 patient samples (44.5%) by immunohistochemistry and/or Western blot analysis. KIT expression was stronger in Ewing tumors showing EWS-FLI1 nontype 1 fusions. Despite absence of c-kit mutations, constitutive and ligand-inducible phosphorylation of KIT was found in all tumor cell lines, indicating an active receptor. Treatment with KIT tyrosine kinase inhibitor imatinib (0.5-20 micro M) induced down-regulation of KIT phosphorylation and dose response inhibition of cell proliferation (IC(50), 12-15 micro M). However, imatinib administered alone at doses close to IC(50) for growth inhibition (10 micro M) did not induce a significant increase in apoptosis. We then analyzed if blockade of KIT loop through imatinib (10 micro M) was able to increase the antitumor in vitro effect of doxorubicin (DXR) and vincristine (VCR), drugs usually used in Ewing tumor treatment. Addition of imatinib decreased in 15-20 and 15-36% of the proliferative rate of Ewing tumor cells exposed to DXR and VCR, respectively, and increased in 15 and 30% of the apoptotic rate of Ewing tumor cells exposed to the same drugs. CONCLUSIONS: Inhibition of Ewing tumor cell proliferation by imatinib is mediated through blockade of KIT receptor signaling. Inhibition of KIT increases sensitivity of these cells to DXR and VCR. This study supports a potential role for imatinib in the treatment of Ewing tumor. 相似文献
996.
Marta Ruiz Hiroya Kobayashi Juan José Lasarte Jesús Prieto Francisco Borrás-Cuesta Esteban Celis Pablo Sarobe 《Clinical cancer research》2004,10(8):2860-2867
PURPOSE: The purpose of this research was to identify promiscuous T-helper cell determinants (THd) from carcinoembryonic antigen (CEA) to be used to prime T-cell help for cancer therapy. CEA was selected because this antigen is expressed in an important variety of carcinomas. EXPERIMENTAL DESIGN: Potential promiscuous THd from CEA were predicted using available computer algorithms. Predicted peptides were synthesized and tested in binding experiments to different HLA-DR molecules. Binder peptides were then used to prime T-cell responses both in vitro and in vivo. RESULTS: Twenty 15-mer peptides from CEA were predicted to bind to different HLA-DR molecules. The promiscuous character of these peptides was demonstrated in binding experiments. Fifteen of 20 peptides tested were able to bind to HLA-DR4, but only CEA (625-639) was shown to be presented after processing of recombinant CEA. CEA (625-639) was also found to be presented by HLA-DR53. Moreover, immunization of HLA-DR4 transgenic mice with CEA (625-639) in conjunction with class I epitope OVA (257-264), induced a CTL response specific of OVA (257-264). CONCLUSIONS: CEA (625-639) might be a relevant promiscuous THd peptide for cancer therapy. 相似文献
997.
Lilia Suárez María-Belén Vidriales José García-Lara?a Guillermo Sanz María-José Moreno Antonio López Susana Barrena Rafael Martínez Mar Tormo Luis Palomera Esperanza Lavilla Ma Consuelo López-Berges María de Santiago M Encarnación Pérez de Equiza Jesús F San Miguel Alberto Orfao 《Clinical cancer research》2004,10(22):7599-7606
Myelodysplastic syndromes and acute myeloid leukemia (AML) are heterogeneous disorders in which conflicting results in apoptosis and multidrug resistance (MDR) have been reported. We have evaluated by multiparameter flow cytometry the expression of apoptosis- (APO2.7, bcl-2, and bax) and MDR-related proteins [P-glycoprotein (P-gp), multidrug resistance protein (MRP), and lung resistance protein (LRP)] specifically on bone marrow (BM) CD34+ cells, and their major CD32-/dim and CD32+ subsets, in de novo AML (n=90), high-risk myelodysplastic syndrome (n=9), and low-risk myelodysplastic syndrome (n=21) patients at diagnosis, and compared with normal BM CD34+ cells (n=6). CD34+ myeloid cells from AML and high-risk myelodysplastic syndrome patients displayed higher expression of bcl-2 (P <0.0001) and lower reactivity for APO2.7 (P=0.002) compared with low-risk myelodysplastic syndrome and normal controls. Similar results applied to the two predefined CD34+ myeloid cell subsets. No significant differences were found in the expression of P-gp, MRP, and LRP between low-risk myelodysplastic syndrome patients and normal BM, but decreased expression of MRP (P <0.03) in AML and high-risk myelodysplastic syndromes and P-gp (P=0.008) in high-risk myelodysplastic syndromes were detected. Hierarchical clustering analysis showed that low-risk myelodysplastic syndrome patients were clustered next to normal BM samples, whereas high-risk myelodysplastic syndromes were clustered together and mixed with the de novo AML patients. In summary, increased resistance to chemotherapy of CD34+ cells from both AML and high-risk myelodysplastic syndromes would be explained more appropriately in terms of an increased antiapoptotic phenotype rather than a MDR phenotype. In low-risk myelodysplastic syndromes abnormally high apoptotic rates would be restricted to the CD34- cell compartments. 相似文献
998.
Pedro José Galindo Fernández Julián Illana Moreno Antonio Piñero Madrona Joaquín Sola Pérez Pascual Parrilla Paricio 《Clinical & translational oncology》2004,6(1):45-47
We present a case of hamartoma of the breast. This is an infrequent tumour that requires the correct diagnosis to distinguish it from other histopathology types because it has a better prognosis. The characteristic image from a mammogram is useful in its diagnosis. 相似文献
999.
Antonio José Conde Moreno Loïc Feuvret George Noel Valentin Calugaru Régis Ferrand Sabine Delacroix Jean-Jacques Mazeron 《Clinical & translational oncology》2004,6(7):403-414
Protons have considerable targeting advantages in the conduct of precise conformational radiotherapy, enabling dose escalation and a better protection of critical organs. Protons differs from photons and electrons used in classical radiotherapy due to their specific physical characteristics, Bragg peak and narrow lateral penumbra. Currently, treatment of ocular melanoma, chordoma and chondrosarcoma of the base of skull and paediatric tumours are widely accepted. Others clinical indications are still being evaluated (meningioma, etc.). Generalised isocentric application and proton intensity modulation can increase the clinical indications for its use. It is a technique which, despite its current expansion, appears “restricted” because of the scarcity of equipments due to its high cost. 相似文献
1000.